Aktie A053950 KYUNG NAM PHARM CO.,LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kyung Nam Pharm Co.,Ltd.

Aktien

A053950

KR7053950002

A053950

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 28.05.2024 		% 5 Tage % 1. Jan.
1.122 KRW -0,09 % Intraday Chart für Kyung Nam Pharm Co.,Ltd. -25,20 % -33,29 %
2023 Kyung Nam Pharm Co.,Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
Kyung Nam Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Kyung Nam Pharm Co.,Ltd. agreed to acquire 9.94% stake in ILYA Co., Ltd from Kang, Jae Woo and Han, Seung Ja for KRW 7 billion.
Enterpartners Co., LTD announced that it expects to receive KRW 26.599899939 billion in funding from Kyung Nam Pharm Co.,Ltd.
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD.
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 8 billion in funding from Metaplex Co., Ltd., and other investors
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 8 billion in funding from Metaplex Co., Ltd., and other investors
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.
Kyung Nam Pharm Co.,Ltd., Virtualtek Corp and Ventage Partners Co., Ltd. agreed to acquire 9.32% stake in Livefinancial Co.,Ltd. for KRW 5.8 billion.
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD.
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD.
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 20.49998703 billion in funding from BioGenetics CO.,LTD., Liveplex Co.,Ltd., CTGen Co.,Ltd., Widwin Investment Co., Ltd.
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 6.49999411 billion in funding from BioGenetics CO.,LTD.
BioGenetics CO.,LTD. acquired additional unknown stake in Kyung Nam Pharm Co.,Ltd. for KRW 22.5 billion.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A053950 Aktie
  4. Nachrichten Kyung Nam Pharm Co.,Ltd.
  5. Andere Sprachen